Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2011

May 12, 2011

30145_dirs_2011-05-12_dadadcf8-dd34-4351-9114-d774184f9d30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2011-05-10

Reporting Person: McCulley Steven E (Vice President & Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-10 Humana Common S 605 $77.14 Disposed 14617 Direct
2011-05-11 Humana Common S 4626 $77.709 Disposed 9991 Direct
2011-05-11 Humana Common M 8110 $62.10 Acquired 18101 Direct
2011-05-11 Humana Common M 6839 $69.475 Acquired 24940 Direct
2011-05-11 Humana Common M 6998 $45.975 Acquired 31938 Direct
2011-05-11 Humana Common M 6665 $41.83 Acquired 38603 Direct
2011-05-11 Humana Common S 25563 $78.0596 Disposed 13040 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-11 Options $62.10 M 8110 Disposed 2014-02-22 Humana Common (8110) Direct
2011-05-11 Options $69.475 M 6839 Disposed 2015-02-21 Humana Common (6839) Direct
2011-05-11 Options $45.975 M 6998 Disposed 2015-04-01 Humana Common (6998) Direct
2011-05-11 Options $41.83 M 6665 Disposed 2016-02-19 Humana Common (6665) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 691 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Humana Common (3879) 3879 Direct
Restricted Stock Units $ Humana Common (8990) 8990 Direct
Phantom Stock Units $ Humana Common (7) 7 Indirect

Footnotes

F1: Stock units held for the benefit of reporting person as of April 30, 2011 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan.

F3: Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.

F4: Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.

F5: Incentive and Non-Qualified stock options granted to reporting person on 4/1/08, NQ options vesting in three increments from 4/1/11 to 4/1/13, and ISO's vesting in two increments on 4/1/12 and 4/1/13.

F6: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.

F7: Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.

F8: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9: Restricted stock units granted to reporting person on 2/18/10, 100% of the award is vesting on 2/18/13.

F10: Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.

F11: Phantom Stock Units held for the benefit of reporting person as of April 30, 2011 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Excess Plan exempt under Rule 16b-3(c and d).

F12: The shares sold in multiple lots ranging from $77.702 to $77.722. The weighted average sale price was $77.7090.

F13: The shares sold in multiple lots ranging from $77.97 to $78.1408. The weighted average sale price was $78.0596.